These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34743349)

  • 21. Clinicopathological features in patients with hepatic graft-versus-host disease.
    Chiba T; Yokosuka O; Goto S; Fukai K; Imazeki F; Kohno Y; Nishimura M; Saito Y; Saisho H
    Hepatogastroenterology; 2005; 52(66):1849-53. PubMed ID: 16334791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-γ-Stimulated Apoptotic Keratinocytes Promote Sclerodermatous Changes in Chronic Graft-Versus-Host Disease.
    Saito A; Ichimura Y; Kubota N; Tanaka R; Nakamura Y; Fujisawa Y; Watanabe R; Ishitsuka Y; Fujimoto M; Okiyama N
    J Invest Dermatol; 2021 Jun; 141(6):1473-1481.e4. PubMed ID: 33242500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular lipomatous metaplasia following myocardial infarction.
    Arnold JR; Karamitsos TD; Pegg TJ; Francis JM; Neubauer S
    Int J Cardiol; 2009 Sep; 137(1):e11-2. PubMed ID: 18674834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
    Olson KA; West K; McCarthy PL
    Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peyronie's disease as a complication of chronic graft versus host disease.
    Grigg AP; Underhill C; Russell J; Sale G
    Hematology; 2002 Jun; 7(3):165-8. PubMed ID: 12243979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Loughran TP; Sullivan K; Morton T; Beckham C; Schubert M; Witherspoon R; Sale G; Sanders J; Fisher L; Shulman H
    Blood; 1990 Jul; 76(1):228-34. PubMed ID: 2194590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases.
    Chosidow O; Bagot M; Vernant JP; Roujeau JC; Cordonnier C; Kuentz M; Wechsler J; André C; Touraine R; Revuz J
    J Am Acad Dermatol; 1992 Jan; 26(1):49-55. PubMed ID: 1732335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
    Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A
    Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of chronic cutaneous graft-versus-host disease in Japanese leukemia patients after bone marrow transplantation: low incidence and mild manifestations of skin lesions.
    Fujii H; Hiketa T; Matsumoto Y; Ohashi M; Miyamura Y; Tanimoto M; Morishima Y; Saito H; Horibe K; Shibata Y
    Bone Marrow Transplant; 1992 Oct; 10(4):331-5. PubMed ID: 1422488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histologic features of graft-versus-host disease-associated angiomatosis: Insights into pathophysiology and treatment.
    Li DJ; Romar GA; Hsieh PC; Wells M; Foreman RK; Lian CG; Divito SJ
    J Am Acad Dermatol; 2020 Sep; 83(3):914-917. PubMed ID: 31923444
    [No Abstract]   [Full Text] [Related]  

  • 32. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
    Yeager AM; Vogelsang GB; Jones RJ; Farmer ER; Altomonte V; Hess AD; Santos GW
    Blood; 1992 Jun; 79(11):3031-5. PubMed ID: 1586747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An analysis of sclerodermatous graft-versus-host-disease after allogeneic bone marrow transplantation: CD8+CD57+T-cell proliferation and increased production of TGF-beta].
    Nakazawa Y; Koike K; Kitazawa Y; Sakashita K; Sawai N; Matsumoto K; Ito S; Kumagai T; Yamada M; Komiyama A
    Rinsho Ketsueki; 1998 Mar; 39(3):185-92. PubMed ID: 9577641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model.
    Lim JY; Ryu DB; Lee SE; Park G; Min CK
    J Invest Dermatol; 2017 Sep; 137(9):1895-1904. PubMed ID: 28526296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
    Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
    J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography.
    Gottlöber P; Leiter U; Friedrich W; Bunjes D; Schulz A; Kerscher M; Peter RU
    J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):402-7. PubMed ID: 12834449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Graft-versus-host disease: Review of 22 cases].
    Steels E; Meuleman N; Vereecken P; de Saint Aubain N; De Dobbeleer G; Bron D; Heenen M
    Acta Clin Belg; 2004; 59(4):182-8. PubMed ID: 15597724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histological diagnosis of cutaneous graft versus host disease: relationship of skin changes to marrow purging and other clinical variables.
    Elliott CJ; Sloane JP; Sanderson KV; Vincent M; Shepherd V; Powles R
    Histopathology; 1987 Feb; 11(2):145-55. PubMed ID: 3552928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation.
    Zhou Y; Barnett MJ; Rivers JK
    Arch Dermatol; 2000 Jun; 136(6):717-21. PubMed ID: 10871932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.